

In collaboration with
Samarkand State Medical University
Clinical & Molecular Biomedicine publishes research that connects molecular discoveries with clinically meaningful applications and supports translational medicine.
The journal welcomes interdisciplinary work spanning molecular and cellular biology, clinical biochemistry, genomics and epigenetics, proteomics and metabolomics, microbiome research, molecular oncology, neurobiology, biomarker discovery, drug discovery and resistance, gene and cell therapy, precision medicine, and immunology and vaccinology.
CMB values experimental, computational, and clinical studies that improve understanding of disease mechanisms and contribute to better diagnosis, treatment, and patient care.
International peer-reviewed journal
Fully open-access publication
Creative Commons Attribution (CC BY) license
No article processing charge (APC)
CMB sits within medicine and health sciences while focusing strongly on molecular and translational biomedicine.
Its published scope includes translational medicine, molecular and cellular biology, clinical biochemistry, genomics, epigenetics, proteomics, metabolomics, microbiome research, oncology, neurobiology, biomarker discovery, drug discovery, gene and cell therapy, precision medicine, immunology, and vaccinology.
Electronic ISSN: 2345-2985
Print ISSN: not specified in the provided journal documents
All articles are published in immediate open access under the CC BY license so they can be read, shared, and reused with proper attribution.
The journal documents state that article processing charges are FREE.
Every submission first undergoes editorial suitability screening.
Suitable manuscripts typically proceed to single anonymized review by at least two independent experts.
Final editorial decisions are made by the journal editors after review and revision.
© 2026 Clinical & Molecular Biomedicine. All rights reserved.
© 2026 EditoryPress. All rights reserved.